APPLICATION
ANDA040710
TYPE
ANDA
ORIGINAL APPROVAL
2007-02-27
LATEST ACTION
2020-02-21
ROUTE
ORAL, TOPICAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
LIDOCAINE HYDROCHLORIDEPrescription
LIDOCAINE HYDROCHLORIDE 4% · SOLUTION · TOPICAL
Approval history
2020-02-21Labeling · Supplement 8 · standardAP
2007-02-27OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.